Industry
Medical - Devices
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Newsdesk
September 06, 2023 | 1:56 pm
Portfolio Pulse from Benzinga Newsdesk
August 30, 2023 | 3:17 pm
Portfolio Pulse from Lisa Levin
August 30, 2023 | 2:37 pm
Portfolio Pulse from Lisa Levin
August 30, 2023 | 1:28 pm
Portfolio Pulse from Benzinga Insights
August 29, 2023 | 6:37 pm
Portfolio Pulse from Benzinga Newsdesk
August 28, 2023 | 10:01 am
Portfolio Pulse from Benzinga Insights
August 24, 2023 | 5:00 pm
Portfolio Pulse from Benzinga Newsdesk
August 24, 2023 | 4:23 pm
Portfolio Pulse from Benzinga Newsdesk
August 24, 2023 | 1:35 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.